Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5-7 Years: From The DISAPEAR Trial And A Meta-Analysis Of The Absorb Stent From Abbott

Value And Advantages Of Eluvia DESs (Boston Scientific) For Lower Extremity Occlusive Lesions: When To Use Them And How To Optimize Their Results

Value Of High-Pressure Non-Compliant Balloons For BTK Arterial Lesion Treatment: Why They Work Better And Other Technical Tips

Technical Tips For Retrograde Tibial And Pedal Access Under Ultrasound (Duplex) Guidance: Contraindications When Fluoro Is Better